Impact of cannabidiol on reward- and stress-related neurocognitive processes among individuals with opioid use disorder: A pilot, double-blind, placebo-controlled, randomized cross-over trial

INTRODUCTION: Opioid use disorder (OUD) continues to be a significant public health concern. Medications for OUD (MOUD) such as buprenorphine reduce overdose mortality, but relapses occur often, leading to adverse outcomes. Preliminary data suggest that cannabidiol (CBD) may be a potential adjunctiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Joji, Prostko, Sara, Szpak, Veronica, Chai, Peter R., Spagnolo, Primavera A., Tenenbaum, Ruth E., Ahmed, Saeed, Weiss, Roger D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098189/
https://www.ncbi.nlm.nih.gov/pubmed/37065899
http://dx.doi.org/10.3389/fpsyt.2023.1155984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098189/
https://www.ncbi.nlm.nih.gov/pubmed/37065899
http://dx.doi.org/10.3389/fpsyt.2023.1155984

Ejemplares similares